Global Health, incorporated in the year 2004, is a Small Cap company (having a market cap of Rs 13513.84 Crore) operating in General sector.
Global Health key Products/Revenue Segments include Hospital Services, Pharmaceuticals and Other Operating Revenue for the year ending 31-Mar-2022.
Financials
For the quarter ended 31-12-2022, the company has reported a Consolidated Total Income of Rs 706.23 Crore, up 1.68 % from last quarter Total Income of Rs 694.57 Crore and up 19.01 % from last year same quarter Total Income of Rs 593.40 Crore. Company has reported net profit after tax of Rs 80.61 Crore in latest quarter.
The company’s top management includes Dr.Naresh Trehan, Mr.Sunil Sachdeva, Mr.Ravi Kant Jaipuria, Mr.Venkatesh Ratnasami, Ms.Praveen Mahajan, Mr.Vikram Singh Mehta, Mr.Hari Shanker Bhartia, Mr.Rajan Bharti Mittal, Mr.Ravi Gupta. Company has Walker Chandiok & Co. LLP as its auditors. As on 31-12-2022, the company has a total of 27 Crore shares outstanding.
As part of their strategy, Medanta is leveraging its strong brand to create an ecosystem in its catchment area via Medanta Labs, homecare, pharmacy, clinics etc. with minimal capex. Post 3Q, the brokerage increased its FY24/25 earnings by 4%/5% to factor in faster Patna ramp up and margin expansion. The brokerage expects earnings upgrade to continue in 4Q driven by better EBITDA trajectory which can potentially lead to multiple rerating.
Promoter/FII Holdings
Promoters held 33.08 per cent stake in the company as of 31-Dec-2022, while FIIs owned 9.36 per cent, DIIs 12.55 per cent.
Download The Economic Times News App to get Daily Market Updates & Live Business News.